Gail Boudreaux is EVP & CEO & UnitedHealthcare at UNITEDHEALTH GROUP INC (UNH). They have made 11 open-market trades across 6 companies since 2008, most recently 2026-07-17.
CIK 0001287920
7 open-market purchases totalling $8.6M since 2008, against 4 sales. Across 7 scored buys the stock is up 1.8% at ninety days, and 0.4 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 71% | 71% |
| Avg Move | +1.3% | -1.7% | +1.8% |
| Alpha | +2.3% | -2.0% | +0.4% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELV | BUY | 2026-07-17 | 2026-07-17 | $367.79 | $1.0M | +0.2% | +4.0% | +14.1% |
| ELV | BUY | 2025-07-18 | 2025-07-18 | $286.87 | $4.6M | +5.5% | +11.1% | +25.1% |
| ELV | SELL · 10b5-1 | 2024-07-22 | 2024-07-23 | $500.98 | $33.0M | +6.0% | +7.6% | -16.4% |
| ANTM | BUY | 2020-01-30 | 2020-01-31 | $263.70 | $2.0M | +11.2% | +1.9% | +5.5% |
| ZBH | BUY | 2019-02-05 | 2019-02-06 | $119.33 | $500K | +4.7% | +3.1% | +4.6% |
| NVAX | BUY | 2016-09-20 | 2016-09-21 | $1.45 | $145K | -7.1% | -32.1% | -36.6% |
| UNH | SELL | 2014-02-27 | 2014-03-03 | $76.04 | $6.9M | -6.6% | -0.4% | -0.4% |
| UNH | SELL | 2013-02-25 | 2013-02-27 | $54.26 | $4.7M | -6.6% | -0.4% | -0.4% |
| XEL | BUY | 2013-02-15 | 2013-02-19 | $28.08 | $50K | +1.3% | +0.1% | +0.1% |
| UNH | SELL | 2012-09-07 | 2012-09-10 | $54.92 | $3.5M | -6.6% | -0.4% | -0.4% |
| UNH | SELL | 2012-02-23 | 2012-02-24 | $54.92 | $4.8M | -6.6% | -0.4% | -0.4% |
| UNH | SELL · 10b5-1 | 2012-01-11 | 2012-01-13 | $52.53 | $5.6M | -6.6% | -0.4% | -0.4% |
| UNH | BUY | 2008-07-28 | 2008-07-28 | $27.90 | $335K | -6.6% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| GENZ |
| 5,000 |
| — |
| Total | $197.7M |
Shares reported on the most recent Form 4, priced at the 2026-07-17 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.